These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22422806)

  • 41. PLOD2 induced under hypoxia is a novel prognostic factor for hepatocellular carcinoma after curative resection.
    Noda T; Yamamoto H; Takemasa I; Yamada D; Uemura M; Wada H; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
    Liver Int; 2012 Jan; 32(1):110-8. PubMed ID: 22098155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
    Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
    Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinoma.
    Zheng J; Dong P; Gao S; Wang N; Yu F
    Hepatogastroenterology; 2013 May; 60(123):549-52. PubMed ID: 23108086
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.
    Fang F; Luo LB; Tao YM; Wu F; Yang LY
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):409-16. PubMed ID: 19208663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
    Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G
    Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decreased expression of SOX6 confers a poor prognosis in hepatocellular carcinoma.
    Guo X; Yang M; Gu H; Zhao J; Zou L
    Cancer Epidemiol; 2013 Oct; 37(5):732-6. PubMed ID: 23731550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.
    Yang XR; Xu Y; Yu B; Zhou J; Qiu SJ; Shi GM; Zhang BH; Wu WZ; Shi YH; Wu B; Yang GH; Ji Y; Fan J
    Gut; 2010 Jul; 59(7):953-62. PubMed ID: 20442200
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cystine/glutamic acid transporter is a novel marker for predicting poor survival in patients with hepatocellular carcinoma.
    Kinoshita H; Okabe H; Beppu T; Chikamoto A; Hayashi H; Imai K; Mima K; Nakagawa S; Ishimoto T; Miyake K; Yokoyama N; Ishiko T; Baba H
    Oncol Rep; 2013 Feb; 29(2):685-9. PubMed ID: 23229496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NEMO expression in human hepatocellular carcinoma and its association with clinical outcome.
    Aigelsreiter A; Haybaeck J; Schauer S; Kiesslich T; Bettermann K; Griessbacher A; Stojakovic T; Bauernhofer T; Samonigg H; Kornprat P; Lackner C; Pichler M
    Hum Pathol; 2012 Jul; 43(7):1012-9. PubMed ID: 22176836
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
    Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor.
    Fujii T; Koshikawa K; Nomoto S; Okochi O; Kaneko T; Inoue S; Yatabe Y; Takeda S; Nakao A
    J Hepatol; 2004 Jul; 41(1):104-11. PubMed ID: 15246215
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
    Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma.
    Zhang HK; Pan K; Wang H; Weng DS; Song HF; Zhou J; Huang W; Li JJ; Chen MS; Xia JC
    Cancer Lett; 2008 Mar; 261(2):183-92. PubMed ID: 18160212
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Importin-α1 as a novel prognostic target for hepatocellular carcinoma.
    Yoshitake K; Tanaka S; Mogushi K; Aihara A; Murakata A; Matsumura S; Mitsunori Y; Yasen M; Ban D; Noguchi N; Irie T; Kudo A; Nakamura N; Tanaka H; Arii S
    Ann Surg Oncol; 2011 Jul; 18(7):2093-103. PubMed ID: 21286940
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predicting the prognosis of hepatocellular carcinoma using gene expression.
    Chang SH; Suh KS; Yi NJ; Lee KH; Kim BY; Jang JJ
    J Surg Res; 2011 Dec; 171(2):524-31. PubMed ID: 20828739
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of cancer-testis antigen (CTA) in tumor tissues and peripheral blood of Chinese patients with hepatocellular carcinoma.
    Wu LQ; Lu Y; Wang XF; Lv ZH; Zhang B; Yang JY
    Life Sci; 2006 Jul; 79(8):744-8. PubMed ID: 16546222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma.
    Köberle V; Kronenberger B; Pleli T; Trojan J; Imelmann E; Peveling-Oberhag J; Welker MW; Elhendawy M; Zeuzem S; Piiper A; Waidmann O
    Eur J Cancer; 2013 Nov; 49(16):3442-9. PubMed ID: 23810247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated serum vitamin B(12) levels in association with tumor markers as the prognostic factors predictive for poor survival in patients with hepatocellular carcinoma.
    Lin CY; Kuo CS; Lu CL; Wu MY; Huang RF
    Nutr Cancer; 2010; 62(2):190-7. PubMed ID: 20099193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
    Ikeguchi M; Hirooka Y; Kaibara N
    Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.